8-KLeadership ChangesExhibits & Filings

Elevance Health, Inc. 8-K Report, Executive Changes (Apr 23, 2013)

Filed April 23, 2013For Securities:ELV

Summary

This 8-K filing from WellPoint, Inc. (now Elevance Health) on April 23, 2013, primarily announces a modification to an executive's employment agreement. Specifically, it details the second amendment to the employment agreement for Richard C. Zoretic, Executive Vice President of Medicaid Programs. The key change is the removal of 'change of control tax gross-up provisions' from his agreement. For investors, this filing is notable as it indicates a proactive step by the company to adjust executive compensation arrangements. The removal of change of control provisions could suggest a shift in the company's strategic outlook or a desire to streamline executive compensation structures, potentially aligning them more closely with standard practices or future corporate actions. While not a material financial event, it provides insight into the company's corporate governance and executive management practices.

Key Highlights

  • 1WellPoint, Inc. filed an 8-K on April 23, 2013.
  • 2The filing concerns an amendment to an executive's employment agreement.
  • 3Richard C. Zoretic, EVP of Medicaid Programs, is the executive involved.
  • 4The Second Amendment removes 'change of control tax gross-up provisions' from Mr. Zoretic's employment agreement.
  • 5This change was effective as of April 23, 2013.
  • 6The amendment is filed as Exhibit 10.16(b).

Frequently Asked Questions

The main purpose of this 8-K filing is to report an amendment to the employment agreement of Richard C. Zoretic, Executive Vice President of Medicaid Programs, specifically to remove change of control tax gross-up provisions.

These provisions typically stipulate that if an executive's employment is terminated under certain circumstances related to a change in the company's ownership or control, the company will reimburse the executive for any excise taxes incurred on parachute payments.

Companies may remove these provisions to reduce potential liabilities, align executive compensation with current market practices, or as part of a broader review of executive compensation policies. It could also signal a change in strategic planning or a move towards greater standardization of executive contracts.

While not a direct financial transaction or earnings report, the amendment is relevant to corporate governance and executive compensation. The removal of these provisions could have implications for future executive payout structures in the event of a change of control, which investors may consider in their assessment of executive compensation and company strategy.